Vibegron
Generic name: Vibegron
Brand names: Gemtesa
Dosage form: oral tablet
Drug class:
Urinary antispasmodics
Usage of Vibegron
Vibegron is a type of drug called a beta-3 agonist. It is used to treat overactive bladder. Overactive bladder is a condition which causes a frequent and sudden urge to urinate that is hard to control.
Vibegron works by activating beta-3 adrenergic receptors in the bladder. This relaxes the main muscle in the bladder wall - the detrusor smooth muscle - while the bladder is filling. Relaxation of the detrusor smooth muscle allows you to hold more urine in your bladder, which helps to treat the symptoms of overactive bladder
Vibegron was approved by the US Food and Drug Administration (FDA) in December 2020 and launched under the brand name Gemtesa the following year.
Vibegron side effects
Vibegron may cause serious side effects including:
The most common side effects of vibegron include:
These are not all the possible side effects of vibegron. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Vibegron
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if vibegron will harm your unborn baby.
Tell your doctor if your are breastfeeding or plan to breastfeed. It is not known if vibegron passes into your breast milk. Talk to your doctor about the best way to feed your baby if you take vibegron.
Relate drugs
- Anturol
- Atropine, hyoscyamine, methenamine, methylene blue, phenyl salicylate, and benzoic acid
- Azuphen MB
- Myrbetriq
- Myrbetriq Granules
- Darifenacin
- Detrol
- Detrol LA
- Ditropan
- Ditropan XL
- Enablex
- Fesoterodine
- Flavoxate
- Gelnique
- Gelnique transdermal
- Gemtesa
- Hyolev MB
- Hyoscyamine, methenamine, methylene blue, and sodium biphosphate
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, and sodium phosphate
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate
- Mirabegron
- Oxybutynin
- Oxybutynin (Oral)
- Oxybutynin transdermal
- Oxytrol
- Phosphasal
- Prosed EC
- Sanctura
- Sanctura XR
- Solifenacin
- Tolterodine
- Toviaz
- Trac Tabs
- Trospium
- UR N-C
- Uramit MB
- Urelle
- Uretron D/S
- Uribel
- Urimar-T
- Urin D/S
- Urised
- Urispas
- Uro-L
- Uro-MP
- Urogesic-Blue
- Ustell
- UTA
- Uticap
- Utira-C
- Utrona-C
- VESIcare
- VESIcare LS
- Vibegron
- Vilamit MB
- Vilevev MB
How to use Vibegron
The recommended dose of vibegron is one 75 mg tablet once daily.
See full prescribing information for more information about vibegron dosing.
What other drugs will affect Vibegron
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your doctor if you take medicines that contain digoxin. Your blood levels of digoxin should be monitored before, during and after treatment with vibegron because treatment with vibegron may affect the dose of digoxin you should take.
Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions